Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer

This study is ongoing, but not recruiting participants.

Study NCT00003577. Last updated on November 21, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00003577

Locations


United Kingdom, England
	University of Cambridge
	Cambridge, England, United Kingdom, CB2 2QQ

Sponsors and Collaborators

University Hospital Birmingham

Investigators


Study Chair:	Helena Earl, MBBS, PhD, FRCP	Cambridge University Hospitals NHS Foundation Trust